PROGRAM CHAIR & FACULTY PRESENTER
Charles W. Hoge, MD, COL(Ret), U.S. Army
Author: Once a Warrior – Always a Warrior
Former Director of Division of Psychiatry and Neuroscience, Walter Reed Army Institute of Research
Internationally Recognized Expert in Service-Related Mental Health Conditions
PROGRAM OVERVIEW
This series focuses on understanding and treating Post-Traumatic Stress Disorder (PTSD), with a special emphasis on veterans. Participants will explore the burden and epidemiology of PTSD, the neurobiology underlying the disorder, and current treatment approaches, including pharmacological and psychotherapeutic options. The program will also cover best practices for using validated screening tools and trauma-informed care in clinical evaluations. Additionally, it will review clinical guidelines and emerging therapies for PTSD, equipping clinicians with the knowledge to provide effective, evidence-based care.
TARGET AUDIENCE
The intended audience includes US-based HCPs in the Veterans Health Administration involved in the care of Veteran patients with post-traumatic stress disorder (PTSD), including primary care clinicians, psychiatrists, and obstetricians/gynecologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Examine the burden and epidemiology of post-traumatic stress disorder (PTSD), with particular focus on PTSD in veterans
- Outline PTSD neurobiology and hypothesized mechanisms underlying treatment approaches (pharmacological and therapeutic)
- Apply best practices for using validated screening tools in assessment of PTSD and trauma-informed approaches to the clinical evaluation of PTSD in primary and specialty care
- Assess evidence and clinical practice guidelines regarding the use of both pharmacologic and psychotherapeutic treatments for PTSD, including emerging and investigational therapies
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Charles W. Hoge, MD, COL(Ret), U.S. Army has nothing to disclose.
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Naomi De Brito, Program Manager for Med Learning Group, has nothing to disclose.
- Sarah Milano, RN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Debbie Anderson, Medical Director for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager, Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: February 28, 2025
EXPIRATION DATE: February 28, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
